MoonLake Immunotherapeutics
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2023 | — | $495.7M | $451.2M |
| FY2024 | $0 | $446.8M | $180.4M |
| FY2025 | $74.1M | $304.5M | $334.5M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2023 | — | $495.7M | $451.2M |
| FY2024 | $0 | $446.8M | $180.4M |
| FY2025 | $74.1M | $304.5M | $334.5M |